from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A particular drug used in chemotherapy.


Sorry, no etymologies found.


  • Kruger found that treating yeast and mammalian cells with a drug called bortezomib elevated the amount of available Hsp70 and rescued mutant proteins. - latest science and technology news stories

  • But that may not be wise if you are being treated for certain types of blood cancer with bortezomib, which is sold under the brand name Velcade.

    New Scientist - Online News

  • Background material for the study notes that some drugs, such as bortezomib, which now treat other cancers, may even have that capability, and an early-stage clinical trial using bortezomib for glioblastoma is currently taking place at Northwestern.

    Yahoo! News: Business - Opinion

  • The progression-free survival of 12.6 months is considered long compared to other targeted agents used in a similar population such as bortezomib (Velcade (R)) where the median time to progression was reported at 7.9 months.

    The Earth Times Online Newspaper

  • Blocking the proteolytic activity of the proteasome by either pharmacological inhibitors such as bortezomib / PS-341 or by polyglutamine repeat containing polypeptides severely compromises ERAD, induces accumulation of misfolded proteins within the ER lumen and imposes ER stress

    PLoS ONE Alerts: New Articles

  • The potential use of Curaxins as adjuvants to cancer therapies inducing proteotoxic stress, such as bortezomib (Velcade�) or thermotherapy, opens a whole new avenue of potential treatment options that may broaden the spectrum of responding tumors by cutting off an escape mechanism.


  • This website also details the role of such drugs as Avastin and bortezomib.

    The Emperor of All Maladies

  • Many of the proteins which are associated with multiple myeloma are known client proteins of Hsp90 and following treatment with bortezomib, Hsp90 related proteins are known to increase as a mechanism of resistance.


  • The Phase 1, open-label, multi-center trial is designed to study ganetespib, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma.


  • Phase 1 trial evaluating ganetespib as a single agent and in combination with the proteasome inhibitor bortezomib for the treatment of relapsed multiple myeloma.



Log in or sign up to get involved in the conversation. It's quick and easy.